Webinar: Updates on New Treatments for Patients with IDH-mutant Gliomas
Hosted by the International Low Grade Glioma Registry
Date: April 30, 2025
Time: 12:00 PM EDT
Duration: 45 minutes
On April 30 2025, the LGG Registry hosted an informative 45-minute webinar featuring UCSF neuro-oncologist Dr. Jennie W. Taylor, who discussed recent advancements in the treatment of IDH-mutant gliomas. Topics include:
FDA-approved therapies
Molecular insights
Community engagement in research
Emerging strategies to improve health outcomes in patients with IDH-mutant gliomas
A recording of the webinar is accessible below.
Online Survey on IDH Inhibitors
The International Low Grade Glioma (LGG) Registry is conducting a survey to assess knowledge and use of a new class of LGG treatment, called IDH inhibitors. This survey is intended to be answered by individuals with LGG and should take approximately 5-10 minutes to complete. Your responses will remain strictly confidential. If interested, please complete the survey below.
Featured
Guest Speaker: Jennie W. Taylor, MD, MPH
Associate Professor of Clinical Neurology, UCSF; Community Engagement Liaison, Neurologic Oncology Program,
Helen Diller Family Comprehensive Cancer Center
Moderator: Elizabeth B. Claus, MD, PhD
Attending Neurosurgeon at Brigham & Women’s Hospital; Professor, Yale University; Founder of the International Low-Grade Glioma Registry; Principal Investigator, OPTIMUM study